Annual Current Liabilities
$6.87 M
-$3.88 M-36.11%
December 31, 2023
Summary
- As of March 13, 2025, CRVS annual total current liabilities is $6.87 million, with the most recent change of -$3.88 million (-36.11%) on December 31, 2023.
- During the last 3 years, CRVS annual current liabilities has fallen by -$5.28 million (-43.46%).
- CRVS annual current liabilities is now -43.46% below its all-time high of $12.15 million, reached on December 31, 2020.
Performance
CRVS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$46.41 M
+$33.07 M+248.00%
September 30, 2024
Summary
- As of March 13, 2025, CRVS quarterly total current liabilities is $46.41 million, with the most recent change of +$33.07 million (+248.00%) on September 30, 2024.
- Over the past year, CRVS quarterly current liabilities has increased by +$39.11 million (+535.79%).
- CRVS quarterly current liabilities is now at all-time high.
Performance
CRVS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CRVS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.1% | +535.8% |
| 3 y3 years | -43.5% | +331.6% |
| 5 y5 years | -2.3% | +331.6% |
CRVS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -36.1% | at low | at high | +590.6% |
| 5 y | 5-year | -43.5% | at low | at high | +590.6% |
| alltime | all time | -43.5% | +156.9% | at high | +5016.4% |
Corvus Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $46.41 M(+248.0%) |
| Jun 2024 | - | $13.34 M(+98.4%) |
| Mar 2024 | - | $6.72 M(-2.2%) |
| Dec 2023 | $6.87 M(-36.1%) | $6.87 M(-5.9%) |
| Sep 2023 | - | $7.30 M(-7.1%) |
| Jun 2023 | - | $7.86 M(-5.2%) |
| Mar 2023 | - | $8.29 M(-22.9%) |
| Dec 2022 | $10.75 M(+10.9%) | $10.75 M(-23.1%) |
| Sep 2022 | - | $13.98 M(+37.6%) |
| Jun 2022 | - | $10.16 M(+9.6%) |
| Mar 2022 | - | $9.27 M(-4.4%) |
| Dec 2021 | $9.69 M(-20.2%) | $9.69 M(-14.3%) |
| Sep 2021 | - | $11.30 M(-8.5%) |
| Jun 2021 | - | $12.36 M(-11.2%) |
| Mar 2021 | - | $13.92 M(+14.5%) |
| Dec 2020 | $12.15 M(+18.8%) | $12.15 M(+1.2%) |
| Sep 2020 | - | $12.00 M(+3.9%) |
| Jun 2020 | - | $11.55 M(-1.4%) |
| Mar 2020 | - | $11.71 M(+14.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $10.22 M(+45.5%) | $10.22 M(+7.4%) |
| Sep 2019 | - | $9.52 M(-11.1%) |
| Jun 2019 | - | $10.70 M(+23.9%) |
| Mar 2019 | - | $8.63 M(+22.9%) |
| Dec 2018 | $7.03 M(-21.7%) | $7.03 M(-9.3%) |
| Sep 2018 | - | $7.75 M(-20.8%) |
| Jun 2018 | - | $9.78 M(-7.8%) |
| Mar 2018 | - | $10.60 M(+18.2%) |
| Dec 2017 | $8.97 M(+50.9%) | $8.97 M(-10.1%) |
| Sep 2017 | - | $9.97 M(+4.8%) |
| Jun 2017 | - | $9.52 M(+25.6%) |
| Mar 2017 | - | $7.58 M(+27.5%) |
| Dec 2016 | $5.94 M(+93.6%) | $5.94 M(+6.2%) |
| Sep 2016 | - | $5.60 M(+55.1%) |
| Jun 2016 | - | $3.61 M(+6.6%) |
| Mar 2016 | - | $3.38 M(+10.2%) |
| Dec 2015 | $3.07 M(+14.8%) | $3.07 M(+238.5%) |
| Sep 2015 | - | $907.00 K |
| Dec 2014 | $2.67 M | - |
FAQ
- What is Corvus Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals annual current liabilities year-on-year change?
- What is Corvus Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals quarterly current liabilities year-on-year change?
What is Corvus Pharmaceuticals annual total current liabilities?
The current annual current liabilities of CRVS is $6.87 M
What is the all time high annual current liabilities for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high annual total current liabilities is $12.15 M
What is Corvus Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, CRVS annual total current liabilities has changed by -$3.88 M (-36.11%)
What is Corvus Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of CRVS is $46.41 M
What is the all time high quarterly current liabilities for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high quarterly total current liabilities is $46.41 M
What is Corvus Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, CRVS quarterly total current liabilities has changed by +$39.11 M (+535.79%)